Lars Akeroyd
Overview
Explore the profile of Lars Akeroyd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
646
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arslan F, Lai R, Smeets M, Akeroyd L, Choo A, Aguor E, et al.
Stem Cell Res
. 2013 Feb;
10(3):301-12.
PMID: 23399448
We have previously identified exosomes as the paracrine factor secreted by mesenchymal stem cells. Recently, we found that the key features of reperfusion injury, namely loss of ATP/NADH, increased oxidative...
2.
Arslan F, Smeets M, Buttari B, Profumo E, Rigano R, Akeroyd L, et al.
J Mol Cell Cardiol
. 2013 Jan;
56:116-28.
PMID: 23274064
Decreased haptoglobin (Hp) functionality due to allelic variations is associated with worsened outcome in patients after myocardial infarction (MI). However, mechanisms through which haptoglobin deficiency impairs cardiac repair remain to...
3.
Arslan F, Houtgraaf J, Keogh B, Kazemi K, De Jong R, McCormack W, et al.
Circ Cardiovasc Interv
. 2012 Feb;
5(2):279-87.
PMID: 22354933
Background: Toll-like receptor (TLR)-2 is an important mediator of innate immunity and ischemia/reperfusion-induced cardiac injury. We have previously shown that TLR2 inhibition reduces infarct size and improves cardiac function in...